Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Simply Good Foods
SMPL
$970M
| $16.6M | 0.03% |
876,004
-2,098,537
| -71% | -$39.6M |
|
802
Markel Group
MKL
$22.5B
| $16.5M | 0.03% |
15,941
+12,900
| +424% | +$14.1M |
|
803
Sarepta Therapeutics
SRPT
$1.92B
| $16.5M | 0.03% |
151,405
-473,335
| -76% | -$59.2M |
|
804
AnaptysBio
ANAB
$1.73B
| $16.5M | 0.03% |
258,624
+166,456
| +181% | +$12.4M |
|
805
Insperity
NSP
$1.99B
| $16.4M | 0.03% |
175,911
+42,046
| +31% | +$4.37M |
|
|
P
806
Everpure Inc
P
$33.4B
| $16.4M | 0.03% |
1,020,514
-405,845
| -28% | -$8M |
|
807
CNA Financial
CNA
$13.4B
| $16.4M | 0.03% |
371,286
+69,504
| +23% | +$3.13M |
|
|
NUVA
808
DELISTED
NuVasive, Inc.
NUVA
| $16.4M | 0.03% |
330,009
-358,771
| -52% | -$21.6M |
|
809
Dropbox
DBX
$7.58B
| $16.3M | 0.03% |
799,808
-112,085
| -12% | -$2.58M |
|
810
Euronet Worldwide
EEFT
$2.63B
| $16.3M | 0.03% |
158,922
+149,062
| +1,512% | +$16.5M |
|
811
Caesars Entertainment
CZR
$6.04B
| $16.2M | 0.03% |
448,083
-1,009,833
| -69% | -$40.1M |
|
|
DOC
812
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $16.1M | 0.03% |
1,007,023
-442,782
| -31% | -$7.42M |
|
813
Inogen
INGN
$146M
| $16.1M | 0.03% |
129,574
+37,457
| +41% | +$6.17M |
|
814
Nu Skin
NUS
$232M
| $16.1M | 0.03% |
262,304
+109,278
| +71% | +$7.37M |
|
|
PGRE
815
DELISTED
Paramount Group
PGRE
| $16.1M | 0.03% |
1,280,717
-48,495
| -4% | -$683K |
|
816
Simon Property Group
SPG
$71.4B
| $16.1M | 0.03% |
95,706
-269,630
| -74% | -$48.2M |
|
817
IDEX
IEX
$17.2B
| $16.1M | 0.03% |
127,324
-103,048
| -45% | -$13.8M |
|
818
Belden
BDC
$4.56B
| $15.9M | 0.02% |
+381,402
| New | +$20.8M |
|
819
Coca-Cola Femsa
KOF
$24.1B
| $15.9M | 0.02% |
261,488
+47,878
| +22% | +$2.9M |
|
|
SC
820
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $15.9M | 0.02% |
904,004
+107,414
| +13% | +$2M |
|
821
Prologis
PLD
$136B
| $15.9M | 0.02% |
270,270
-1,351,640
| -83% | -$87.6M |
|
822
Sinclair Inc
SBGI
$1.05B
| $15.9M | 0.02% |
602,058
+529,007
| +724% | +$15.4M |
|
|
CJ
823
DELISTED
C&J Energy Services, Inc.
CJ
| $15.8M | 0.02% |
1,173,801
-1,124,959
| -49% | -$20.1M |
|
824
Genpact
G
$6.32B
| $15.8M | 0.02% |
586,551
-7,966
| -1% | -$227K |
|
825
Rigel Pharmaceuticals
RIGL
$843M
| $15.8M | 0.02% |
687,580
-75,600
| -10% | -$2.13M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.